Live Breaking News & Updates on வலேரி அர்போலேடா

Stay updated with breaking news from வலேரி அர்போலேடா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SwabSeq platform offers a potential solution for massive COVID-19 testing


SwabSeq platform offers a potential solution for massive COVID-19 testing
In an article appearing in Nature Biomedical Engineering, a team of scientists from the UCLA David Geffen School of Medicine and UCLA School of Engineering report real-world results on SwabSeq, a high-throughput testing platform that uses sequencing to test thousands of samples at a time to detect COVID-19. They were able to perform more than 80,000 tests in less than two months, with the test showing extremely high sensitivity and specificity.
SwabSeq uses sample-specific molecular barcodes to simultaneously analyze thousands of samples for the presence or absence of SARS-CoV-2, the virus that causes COVID-19. SwabSeq was granted FDA Emergency Use Authorization in October and is currently deployed at UCLA in a high-complexity CLIA laboratory, which has performed over 150,000 tests since December 2020. SwabSeq is a flexible protocol and can rapidly scale up testing for novel pathogens, including COVI ....

United States , Los Angeles , Valerie Arboleda , Emily Henderson , University Of California , Department Of Computational Medicine , David Geffen School Of Medicine , Department Of Human Genetics , School Of Engineering , Laboratory Medicine , Department Of Pathology , Los Angeles Health Sciences , Samueli School Of Engineering , Nature Biomedical Engineering , Geffen School , Use Authorization , Lead Scientist , Assistant Professor , Angeles Health , Computational Medicine , David Geffen School , Samueli School , Human Genetics , ஒன்றுபட்டது மாநிலங்களில் , லாஸ் ஏஞ்சல்ஸ் , வலேரி அர்போலேடா ,

17 scientists and researchers receive awards from Technology Development Group


UCLA
March 4, 2021
Seventeen researchers at UCLA have been named recipients of awards from the 2020 UCLA Innovation Fund Biomedical Competition.
These awards, up to $200,000 per project, support early stage research that lead to commercialization activities, which usually aren’t supported by basic research grants. As a result, researchers can develop their technologies to a point where the chances of success are greatly increased. Importantly, all awarded projects receive consultations from an outside industry and investor adviser panel, which provides technical and commercial feedback that is key to technology development.
The UCLA Innovation Fund was established by the UCLA Technology Development Group, in conjunction with the David Geffen School of Medicine at UCLA, UCLA College’s divisions of physical sciences and life sciences, the UCLA Samueli School of Engineering, the School of Dentistry and UCLA Health. ....

Amir Naiberg , Bennett Novitch , Michelle Zeidler , Tamara Grisales , Ronald Harper , Raymond Lim , Valerie Arboleda , Feng Guo , Leena Nathan , Steven Dubinett , Mohammad Mahdi Hasani Sadrabadi , William Lowry , Carrie Miceli , Timothy Deming , Michael Jung , Michael Delong , Innovation Fund , Innovation Fund Biomedical Competition , David Geffen School Of Medicine , Technology Development Corporation , Technology Development Group , School Of Dentistry , Samueli School Of Engineering , Fund Biomedical , Development Group , David Geffen School ,